XON
Intrexon Corporation
NYSE
People also watch:ZIOPJUNOKITEBLUEHALO
25.330.62 (2.51%)

After hours: 25.330.00 (0.00%) as of 7:02 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close24.71
Open24.65
Bid25.21 x 100
Ask25.40 x 3000
52wk Range18.52 - 69.45
Day's Range24.45 - 25.63
Volume820,261
Avg Vol (3m)1,640,941
As of 4:02 PM EDT. Market closed.
  • Intrexon's Genetically Engineered Mosquitoes (Finally) Have Data. What's Next?
    Motley Fool9 days ago

    Intrexon's Genetically Engineered Mosquitoes (Finally) Have Data. What's Next?

    A complete absence of data showing the potential of genetically engineered mosquitoes to benefit public health is no longer the case. However, it may take a few more years before Intrexon investors see significant contributions to the top and bottom line.

  • Intrexon Corp. – Value Analysis (NYSE:XON) : July 18, 2016
    Capital Cube12 days ago

    Intrexon Corp. – Value Analysis (NYSE:XON) : July 18, 2016

    Click here to see latest analysisCapitalcube gives Intrexon Corp. a score of 59.Our analysis is based on comparing Intrexon Corp. with the following peers – ZIOPHARM Oncology, Inc., Eli Lilly and Company, Thermo Fisher Scientific Inc., Odyssey Marine Exploration, Inc., Fibrocell Science, Inc. and Synthetic Biologics, Inc. (ZIOP-US, LLY-US, TMO-US, OMEX-US, FCSC-US and SYN-US).Investment OutlookIntrexon […] (Read more...) The post Intrexon Corp. – Value Analysis (NYSE:XON) : July 18, 2016 appeared first on CapitalCube.